Contract research organization Medpace today released the pricing for its initial public offering, looking to float 7 million shares at between $20 and $23 per share, which will bring in between $140 and $161 million. Private equity shop Cinven paid CCMP Capital Advisors $921.3 million for Cincinnati-based Medpace in 2014. The company originally registered for the […]
Funding Roundup
Tactile Systems reduces IPO to $46m
Leg compression device developer Tactile Systems Technology reduced its initial public offering to $46 million. Those estimates are down approximately 24% from the $60 million it said it hoped to bring in in June, which was 30% less than the $86 million projection the company put up when it registered the IPO in January. The company said on […]
FlexDex Surgical closes $5m Series B, preps launch of laparoscopic tools
FlexDex Surgical said today that it raised a $5 million Series B round it plans to use to advance the laparoscopic surgery tools it’s developing. Get the whole story at our sister site, Medical Design & Outsourcing.
Titan Medical delays close for $16m placement with Chinese private equity firm
Titan Medical (CVE:TMD) added a month to the closing date on a private placement that’s slated to add about $16 million to its coffers. The placement with Chinese private equity player Shanghai Jugu Equity Investment Fund, announced June 1, is now due to close on or before August 15, the Toronto-based robot-assisted surgery firm said. “We have extended […]
Magnetic Insight raises $3m for magnetic particle imaging
Magnetic Insight said today that it raised a $3 million seed round for the magnetic particle imaging technology it’s developing. Alameda, Calif.-based Magnetic Insight said Sand Hill Angels led the round, with participation from ” other prominent angel investors” and funds including the Stanford-StartX Fund. Magnetic particle imaging is designed to detects magnetic nanoparticle tracers for deep-tissue imaging, the […]
Endonovo Therapeutics raises $10m for Rio Grande buy
Endonovo Therapeutics (OTC:ENDV) said today that it raised $10 million it plans to use to fund the $22 million acquisition of Rio Grande Neurosciences. The backing from an unnamed institutional investor consists of $1 million in convertible notes and another $9 million in a securities purchase agreement, Los Angeles-based Endonovo said. The company said it’s received $400,000 […]
Endotronix raises $32m Series C for wireless heart monitor
Endotronix said today that it raised a $32 million Series C round for the wireless heart monitor it’s looking to commercialize. Participants in the round included existing backers and an unnamed strategic investor, plus BioVentures Investors, SV Life Sciences, Lumira Capital, Aperture Venture Partners and OSF Ventures, Woodridge, Ill.-based Endotronix said. “We are pleased to welcome these high-caliber medtech […]
Southlake Equity gets in on Titan Spine
Titan Spine said yesterday that Southlake Equity Group put a “substantial” but unspecified amount into its coffers, as it looks to expand the commercial footprint of its Endoskeleton implants and launch its Nanolock surface technology. “We are thrilled to bring on board an investor that is equally as confident in the milestones we have achieved to […]
Investors put $227m into Minnesota medtech this year
Investors pumped a record $227.4 million into medical device and digital health companies in Minnesota so far this year, according to a report from industry group Medical Alley. Some 64 companies raised capital in the North Star State during the 1st half of 2016, according to the report, eclipsing the $213 million drummed up in 2009. […]
TransMedics adds $13m to $51m funding round
TransMedics said yesterday that it added $12.5 million to the $51.2 million equity round it closed in May, taking its total raise to more than $63.7 million. Andover, Mass.-based TransMedics developed the Organ Care System, which is designed to perfuse donor organs with warm, oxygenated blood and monitor its status until transplantation. “We are thankful and excited to be supported by a […]
Avita Medical pulls down $9m
Avita Medical (ASX:AVH) said yesterday that it raised $9 million in a partially underwritten rights issue for its ReCell device, which is designed to use a patient’s own skin cells to treat burns, chronic wounds and skin defects. Avita, which has offices in Northridge, Calif., Cambridge, U.K. and Perth, Australia, said it issued nearly 100.2 million new shares in the […]